Peptide United

Specimen index

Peptide Database

5 peptides filtered results

GHRP-2

Phase II

Pralmorelin · Growth Hormone-Releasing Peptide 2

GHRP-2 is a synthetic hexapeptide and potent ghrelin receptor agonist that stimulates growth hormone release from the pituitary. It produces a strong GH pulse with some elevation of cortisol and prolactin at higher doses. Research includes GH deficiency diagnosis, body composition, sleep quality, and appetite stimulation via its ghrelin-mimetic mechanism.

C₄₅H₅₅N₉O₆ · 817.99 Da

Growth Hormone AxisSleep & Circadian

GHRP-6

Preclinical

Growth Hormone-Releasing Peptide 6 · His-DTrp-Ala-Trp-DPhe-Lys-NH₂

GHRP-6 is one of the original synthetic GHRPs, acting as a strong ghrelin receptor agonist. It produces robust GH release accompanied by significant appetite stimulation — a property that makes it both valuable for cachexia research and distinct from cleaner GHRPs like Ipamorelin. Research also shows cytoprotective and cardioprotective properties independent of GH secretion.

C₄₆H₅₆N₁₂O₆ · 873.02 Da

Growth Hormone AxisHealing & Recovery

Hexarelin

Phase II

Examorelin · EP 23905

Hexarelin is one of the most potent synthetic GHRP compounds, producing the largest GH pulse among GHRPs. Beyond its GH-stimulating properties, research highlights direct cardioprotective effects through CD36 receptor binding, independent of GH or IGF-1. Studies show benefits in heart failure models, myocardial infarction recovery, and protection against ventricular dysfunction.

Growth Hormone AxisCardiovascular

Ipamorelin

Preclinical

NNC 26-0161

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. Unlike other GHRPs, it stimulates GH release with high selectivity — producing minimal cortisol, ACTH, or prolactin elevation. It is among the most studied GHRPs for its clean GH pulse profile, making it a preferred research peptide for GH axis studies with reduced side effect concern.

C₃₈H₄₉N₉O₅ · 711.86 Da

Growth Hormone Axis

Mod GRF 1-29

Preclinical

CJC-1295 without DAC · Modified GRF 1-29

Mod GRF 1-29 is a modified version of GHRH(1-29) with four amino acid substitutions that increase stability and half-life without the DAC albumin-binding component. It produces a natural, pulsatile GH release and is commonly paired with GHRPs (like Ipamorelin) for a synergistic GH pulse. Its shorter duration preserves natural pituitary feedback mechanisms.

Growth Hormone Axis